Investment
Features
FeesSafety
Academy
More
Pluang+

Russell 3000 index up 3% in H2 but average stock down 4.4% amid rising rates and strong short selling.

Market News
09 Oct 2026
Seeking Alpha
View Source
Bearish
Russell 3000 index up 3% in H2 but average stock down 4.4% amid rising rates and strong short selling.

In the second half of 2026, the Russell 3000 index, representing about 98% of the US stock market, rose roughly 3%. However, the average stock within the index actually fell by 4.4%, highlighting a divergence driven by rising interest rates impacting sensitive sectors. Additionally, heavy short selling appears to be winning, as shorts are not rushing to cover despite the market rally, indicating a cautious or bearish sentiment among investors. This suggests a challenging environment for growth stocks after a strong first half of the year.

The Russell 3000 index's mixed performance in the second half of 2026 provides context for this market snapshot. For readers following US stocks, here is Pluang's market snapshot as of Oct 10, 2026 07:51 WIB: out of 150 priced US stocks tradable on Pluang, 101 rose and 48 fell today. Notable movers include SNOW at USD 368.89 with a 1-day change of +7.42% and Pluang order activity of 90% Sell / 10% Buy, HPQ at USD 30.20 down 6.91% with 27% Sell / 73% Buy, and SNAP at USD 6.24 up 6.31% with 100% Sell / 0% Buy.

More News

Class action lawsuit filed over Compass-Anywhere merger alleging regulatory misrepresentation.

Class action lawsuit filed over Compass-Anywhere merger alleging regulatory misrepresentation.

The Rosen Law Firm has filed a class action lawsuit on behalf of former Anywhere Real Estate shareholders who received Compass, Inc. stock in a January 2026 merger. The suit alleges that Compass and its executives misrepresented their efforts to secu...

Market News
Bearish
1 hour ago
New data supports Furoscix ReadyFlow autoinjector for outpatient edema management in heart failure and CKD.

New data supports Furoscix ReadyFlow autoinjector for outpatient edema management in heart failure and CKD.

MannKind presented new clinical data at HFSA 2026 showing that Furoscix ReadyFlow, an autoinjector delivering subcutaneous furosemide, provides diuretic effects comparable to IV administration for treating edema in heart failure and chronic kidney di...

Market News
Bullish
1 hour ago
Class action lawsuit filed against Millrose Properties over undisclosed $200M property leases causing stock drop

Class action lawsuit filed against Millrose Properties over undisclosed $200M property leases causing stock drop

A securities class action lawsuit was filed against Millrose Properties, Inc. for allegedly misleading investors by not disclosing that it would lease $200 million worth of properties purchased from Lennar at a loss. The lawsuit claims Millrose misre...

Market News
Bearish
1 hour ago
Brookfield Infrastructure delays shareholder meeting to Oct 29 for vote on corporate simplification plan

Brookfield Infrastructure delays shareholder meeting to Oct 29 for vote on corporate simplification plan

Brookfield Infrastructure Corporation has postponed its special shareholder meeting to October 29, 2026, to allow more time for votes on its proposed corporate simplification. The plan aims to merge Brookfield Infrastructure Partners LP and Brookfiel...

Company Fundamentals
Bullish
2 hours ago
Brookfield Renewable delays vote on corporate simplification to Oct 29, citing strong unitholder support.

Brookfield Renewable delays vote on corporate simplification to Oct 29, citing strong unitholder support.

Brookfield Renewable Partners has postponed its special unitholders' meeting to October 29, 2026, to finalize approval for its proposed corporate simplification. Over 99.7% of votes so far favor the plan, which aims to merge Brookfield Renewable Part...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App